In June 2025, the FDA granted Fast Track designation to nuvisertib, a PIM1 kinase inhibitor from Sumitomo Pharma, for ...
The Greek gods in particular, flighty as they are, particularly enjoy the occasional offering, and are more than willing to ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback